Zobrazeno 1 - 10
of 55
pro vyhledávání: '"refractory lupus nephritis"'
Publikováno v:
Pharmacogenomics and Personalized Medicine, Vol Volume 17, Pp 443-452 (2024)
Shanshan Liu, Ju Li, Zhongyuan Zhang, Deqian Meng, Kai Wang Department of Rheumatology and Immunology, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huaian, 223001, People’s Republic of ChinaCorrespondence: Kai Wang
Externí odkaz:
https://doaj.org/article/a239c65c994d46aa9c98bf24d6756435
Autor:
Sijia Li, Shuting Deng, Sichun Wen, Siqi Peng, Nan Jiang, Bohou Li, Boxi Chen, Ye Yuan, Qiong Wu, Yiming Tao, Jianchao Ma, Ting Lin, Feng Wen, Zhuo Li, Hao Dai, Renwei Huang, Zhonglin Feng, Zhilian Li, Shuangxin Liu, Lixia Xu
Publikováno v:
Case Reports in Nephrology and Dialysis, Vol 14, Iss 1, Pp 42-47 (2024)
Introduction: Refractory lupus nephritis (LN) causes kidney disease progression and increases the risk of loss of renal function. Due to the high specificity and few side effects of biological agents, they are recommended for the treatment of systemi
Externí odkaz:
https://doaj.org/article/4abf39666ec040f6a83a5b9e251a8c4b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shuo Zhang, Yiran Chen, Xin Chen, Yan Zhao, Xiaofeng Zeng, Fengchun Zhang, Li Wang, Mengtao Li
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe condition of refractory lupus nephritis (LN) negatively affects the prognosis and life expectancy of the patients, posing a challenge to manage in clinical. This interventional study evaluated the efficacy as well as safety of lefluno
Externí odkaz:
https://doaj.org/article/92602f2312bc4199a04213c3707e9314
Autor:
Qingran Yan, Mei Zhang, Fang Du, Yuening Kang, Ping Ye, Qianqian Li, Bei Liu, Min Dai, Chunde Bao
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ObjectivesIGU (IGU), a novel immunomodulatory agent for rheumatoid arthritis, has been shown to be effective and safe as monotherapy in a small population with refractory lupus nephritis (LN). The aim of this prospective study was to evaluate the eff
Externí odkaz:
https://doaj.org/article/6e6bc1323ef2489fb10bb89e503e11de
Autor:
Mileka Gilbert, Beatrice Goilav, Joyce J. Hsu, Paul J. Nietert, Esra Meidan, Annabelle Chua, Stacy P. Ardoin, Scott E. Wenderfer, Emily von Scheven, Natasha M. Ruth, for the Pediatric Nephrology and Rheumatology Collaborative Group, the Childhood Arthritis and Rheumatology Research Alliance, and the American Society for Pediatric Nephrology
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 19, Iss 1, Pp 1-10 (2021)
Abstract Background Consensus treatment plans have been developed for induction therapy of newly diagnosed proliferative lupus nephritis (LN) in childhood-onset systemic lupus erythematosus. However, patients who do not respond to initial therapy, or
Externí odkaz:
https://doaj.org/article/554cb56ded8c4f1593a7d19d9478ea2e
Autor:
Yuening Kang, Qingran Yan, Qiong Fu, Ran Wang, Min Dai, Fang Du, Qing Dai, Ping Ye, Chunmei Wu, Liangjing Lu, Chunde Bao
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-8 (2020)
Abstract Objectives Iguratimod, a novel immunomodulatory agent for rheumatoid arthritis, has been shown to be effective against murine lupus. The aim of this study was to make a preliminary evaluation of the efficacy and safety of iguratimod as salva
Externí odkaz:
https://doaj.org/article/b0a11c16ddcc4a5bbf7d78c9df523b5b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Open Access Rheumatology: Research and Reviews, Vol Volume 11, Pp 179-188 (2019)
JH Yo, TD Barbour, K NichollsDepartment of Nephrology, The Royal Melbourne Hospital, Melbourne, Victoria, AustraliaAbstract: Refractory lupus nephritis, broadly defined as failure to attain clinical remission after appropriate induction immunosuppres
Externí odkaz:
https://doaj.org/article/4251bc939e1442d8bd42a5072b7bddd1